Foresite Capital Management Closes $100 Million Growth Capital Fund to Finance Late-Stage Healthcare Companies
January 31 2013 - 8:01AM
Marketwired
Foresite Capital Management, LLC, a growth equity firm founded by
Jim Tananbaum to finance late-stage healthcare companies, today
announced the close of its $100 million fund, Foresite Capital Fund
I. The firm draws on Tananbaum and his partners' deep experience
and expertise in building leading healthcare companies, as well as
their broad private and public investment experience.
"We are marrying the best practices of growth investing with
healthcare specialization," said Jim Tananbaum, founder and
managing director of Foresite Capital Management. "We are proud of
our capital base, extremely excited about the prospects for
healthcare growth, and believe on a risk-adjusted basis there has
never been a better time to have this focus."
Foresite Capital invests in companies with disruptive,
late-stage products and services in a broad range of healthcare
from biotechnology, genomics and diagnostics to healthcare services
and medical devices. Current portfolio companies include AcelRx
Pharmaceuticals (NASDAQ: ACRX), Intarcia Therapeutics, Keryx
Biopharmaceuticals (NASDAQ: KERX), Puma Biotechnology (NYSE: PBYI),
Solta Medical (NASDAQ: SLTM), and Tarsa Therapeutics.
About Foresite Capital Management
Foresite Capital Management was founded in 2011 by veteran
healthcare investor Jim Tananbaum based on his vision to build a
firm focused on providing growth capital to healthcare companies
with disruptive late-stage products or services. Foresite Capital
consists of five partners based in San Francisco and New York. The
team has a diverse set of healthcare expertise, deep experience in
private and public healthcare investing, and a strong track record
of building companies and delivering investor returns. During the
last two decades Foresite Capital's partners have led financings
that produced five multi-billion dollar outcomes. The team's
experience also includes leadership positions in operations,
clinical, marketing, business development, communications, and
finance. Foresite Capital is based in San Francisco, California
with an office in Manhattan, New York.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: Brewlife (On behalf of Foresite Capital Management)
http://www.brewlife.com Julie Normart 415-946-1087 Email
Contact
Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart
From Jul 2023 to Jul 2024